biologics

R&D

Jonah Comstock interviews Dr Dhaval Shah at AAPS

Modelling biologics: Challenges and opportunities, with Dr D...

From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.

R&D

Partner Content

Register Now for the AAPS National Biotechnology Conference

The AAPS National Biotechnology Conference uncovers the trends driving today’s biotech markets.

Market Access

Why the NHS needs to maximise the impact of biosimilars

Ensuring the long-term sustainability of the NHS increasingly appears to be an unfathomable prospect.

News

AMD shadows NVIDIA with a move into AI drug discovery

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

News

Sanofi opens $595m manufacturing facility in Singapore

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products

News

Dr Deborah Bitterfield, chief executive and founder of Lindy Biosciences

Push for self-injected drugs prompts Novartis/Lindy alliance

Novartis is putting $20 million upfront into a near-$1 billion deal with US start-up Lindy Biosciences that aims to convert biologic drugs delivered by infusion into therapies that can be s

Modelling biologics: Challenges and opportunities, with Dr D...

Register Now for the AAPS National Biotechnology Conference

Why the NHS needs to maximise the impact of biosimilars

AMD shadows NVIDIA with a move into AI drug discovery

Sanofi opens $595m manufacturing facility in Singapore

Push for self-injected drugs prompts Novartis/Lindy alliance

FDA approves higher Wegovy dose via 4th priority voucher

Using AI-driven synthetic personas to take your insights fur...

biologics

Editor's Picks